Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Solomon

Showing results (1-10 of 184) with videos related to

Pageof 19
Sort By:
Lancet (London, England)|January 28, 2017
First-line treatment options for ALK-rearranged lung cancerBenjamin Solomon
Journal of Oncology Practice|September 13, 2018
Navigating Through New, First-Line Treatment Options for Lung CancerBenjamin Solomon
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2016
Trials and Tribulations of EGFR and MET Inhibitor Combination Therapy in NSCLCBenjamin Solomon
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 29, 2020
Identifying Mechanisms of Resistance to ALK Tyrosine Kinase Inhibitors Using Analysis of Circulating Tumor DNABenjamin Solomon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Validating ROS1 rearrangements as a therapeutic target in non-small-cell lung cancerBenjamin Solomon
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
Refining the toxicity profile of crizotinibBenjamin Solomon
Lancet (London, England)|February 21, 2006
Benjamin Solomon Carson SrBenjamin Solomon Carson
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 13, 2017
Recurrent cisplatin hypersensitivity reaction after first exposure: A case reportBenjamin Solomon, Sarah Colonna
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Progress in molecular targeted therapy for thyroid cancer: vandetanib in medullary thyroid cancerBenjamin Solomon, Danny Rischin
Current Treatment Options in Oncology|August 31, 2015
New Treatment Options for ALK-Rearranged Non-Small Cell Lung CancerLaird Cameron, Benjamin Solomon
Pageof 19

Showing results (1-10 of 184) with videos related to

Sort By:
Pageof 19
Lancet (London, England)|January 28, 2017
First-line treatment options for ALK-rearranged lung cancerBenjamin Solomon
Journal of Oncology Practice|September 13, 2018
Navigating Through New, First-Line Treatment Options for Lung CancerBenjamin Solomon
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2016
Trials and Tribulations of EGFR and MET Inhibitor Combination Therapy in NSCLCBenjamin Solomon
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 29, 2020
Identifying Mechanisms of Resistance to ALK Tyrosine Kinase Inhibitors Using Analysis of Circulating Tumor DNABenjamin Solomon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Validating ROS1 rearrangements as a therapeutic target in non-small-cell lung cancerBenjamin Solomon
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
Refining the toxicity profile of crizotinibBenjamin Solomon
Lancet (London, England)|February 21, 2006
Benjamin Solomon Carson SrBenjamin Solomon Carson
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 13, 2017
Recurrent cisplatin hypersensitivity reaction after first exposure: A case reportBenjamin Solomon, Sarah Colonna
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Progress in molecular targeted therapy for thyroid cancer: vandetanib in medullary thyroid cancerBenjamin Solomon, Danny Rischin
Current Treatment Options in Oncology|August 31, 2015
New Treatment Options for ALK-Rearranged Non-Small Cell Lung CancerLaird Cameron, Benjamin Solomon
Pageof 19